Arena Pharmaceuticals Inc EV/EBIT
Quel est le EV/EBIT de Arena Pharmaceuticals Inc?
Le EV/EBIT de Arena Pharmaceuticals Inc est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à Arena Pharmaceuticals Inc
Que fait Arena Pharmaceuticals Inc?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Entreprises avec ev/ebit similaire à Arena Pharmaceuticals Inc
- Natuzzi S.P.A a EV/EBIT de N/A
- Quotient Ltd a EV/EBIT de N/A
- Vericity a EV/EBIT de N/A
- ARC Worldwide Inc a EV/EBIT de N/A
- Transphorm a EV/EBIT de N/A
- ValiRx plc a EV/EBIT de N/A
- Arena Pharmaceuticals Inc a EV/EBIT de N/A
- Engineer Gold Mines a EV/EBIT de N/A
- EnWave a EV/EBIT de N/A
- Avalon GloboCare a EV/EBIT de N/A
- Compass Venture a EV/EBIT de N/A
- New Talisman Gold Mines a EV/EBIT de N/A
- CG Power and Industrial Solutions a EV/EBIT de N/A